Dechra Pharmaceuticals PLC

LSE:DPH (UK)   Ordinary Shares
£ 38.66 (+0.05%) Jan 15
At Loss
P/B:
5.83
Market Cap:
£ 4.40B ($ 5.55B)
Enterprise V:
£ 4.83B ($ 6.10B)
Volume:
-
Avg Vol (2M):
-
Also Trade In:

Business Description

Description
Dechra Pharmaceuticals PLC is a major drug manufacturing company with a focus on veterinary pharmaceutical products. The company develops, manufactures, and markets its products exclusively for veterinarians globally. Dechra is structured along three segments, including being European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The vast majority of Dechra's revenue is generated in Europe, followed by the U.S. Dechra derives most of its revenue through its Companion Animal Product category, followed by food-producing animal products.
Name Current Vs Industry Vs History
Cash-To-Debt 0.15
Equity-to-Asset 0.48
Debt-to-Equity 0.67
Debt-to-EBITDA 5.17
Interest Coverage 0.14
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.05
Distress
Grey
Safe
Beneish M-Score -2.63
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 79.03
9-Day RSI 74.17
14-Day RSI 71.52
6-1 Month Momentum % 3.84
12-1 Month Momentum % 30.26

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.85
Quick Ratio 1.53
Cash Ratio 0.45
Days Inventory 223.88
Days Sales Outstanding 62.66
Days Payable 83.01

Financials (Next Earnings Date:2024-10-11 Est.)

LSE:DPH's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Dechra Pharmaceuticals PLC Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil £) 761.5
EPS (TTM) (£) -0.247
Beta 0
Volatility % 44.5
14-Day RSI 71.52
14-Day ATR (£) 0.093102
20-Day SMA (£) 38.545
12-1 Month Momentum % 30.26
52-Week Range (£) 24.73323 - 41.45837
Shares Outstanding (Mil) 113.91

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Dechra Pharmaceuticals PLC Filings

Filing Date Document Date Form
No Filing Data

Dechra Pharmaceuticals PLC Stock Events

Financials Calendars
Event Date Price(£)
No Event Data

Dechra Pharmaceuticals PLC Frequently Asked Questions

What is Dechra Pharmaceuticals PLC(LSE:DPH)'s stock price today?
The current price of LSE:DPH is £38.66. The 52 week high of LSE:DPH is £41.46 and 52 week low is £24.73.
When is next earnings date of Dechra Pharmaceuticals PLC(LSE:DPH)?
The next earnings date of Dechra Pharmaceuticals PLC(LSE:DPH) is 2024-10-11 Est..
Does Dechra Pharmaceuticals PLC(LSE:DPH) pay dividends? If so, how much?
The  Dividend Yield %  of Dechra Pharmaceuticals PLC(LSE:DPH) is 0.32% (As of Today), Highest Dividend Payout Ratio of Dechra Pharmaceuticals PLC(LSE:DPH) was 0.48. The lowest was 0.3. And the median was 0.35. The  Forward Dividend Yield % of Dechra Pharmaceuticals PLC(LSE:DPH) is 0%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release